Final rule adds substances to DOT drug panel
Posted November 10, 2017
U. S. Department of Transportation procedures for drug testing will be amended effective January 1, 2018, according to a final rule expected to be published in the Federal Register on November 13, 2017.
Revisions to 49 CFR Part 40 will add the following to the DOT drug-testing panel:
- Oxymorphone, and
In addition, methylenedioxyamphetamine will be added as an initial test analyte, and methylenedioxyethylamphetamine will be removed as a confirmatory test analyte.
The revisions to Part 40 harmonize DOT regulations with the revised Mandatory Guidelines established by the U.S. Department of Health and Human Services for federal drug-testing programs for urine testing.
The changes to Part 40:
- Clarify certain existing drug-testing program provisions and definitions,
- Make technical amendments, and
- Remove the requirement for employers and Consortium/Third Party Administrators to submit blind specimens.
J. J. Keller's Reasonable Suspicion Testing: What Supervisors Need to Know - DVD Training helps fulfill supervisors' required drug and alcohol training.
J. J. Keller's FREE Transportation SafetyClicks™ email newsletter brings quick-read safety and compliance news right to your email box.